Hybridan Small Cap Feast
7 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Latest
Pharmaceuticals and Biotech Are Due For a Rebound
6 mins. to read
Over the last year, defensive stocks have done very well relative to the broad market. Sectors including Health Care, Utilities and Consumer Staples are among the winners in a market haunted by the fear of a global recession.
Hybridan Small Cap Feast
7 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Sureserve Group – Time To Reassess After Results?
3 mins. to read
Mark Watson-Mitchell believes that this firm’s strong order book, cash position and increasing profits exposes undervalued of its shares.
Hybridan Small Cap Feast
9 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Scottish Mortgage Downgraded To Sell
2 mins. to read
It has been a tough period for the country’s biggest investment trust whose growth-oriented portfolio has been hit hard by the sharp increase in interest rates.
Hybridan Small Cap Feast
8 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
CentralNic – Looking Ahead To Q4 Results
5 mins. to read
Mark Watson-Mitchell explains why you shouldn’t underestimate this group’s potential as he sets a new target price.
Hybridan Small Cap Feast
8 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Ad Astra: SpaceX versus Tesla
12 mins. to read
SpaceX will soon be worth more than Tesla. Elon, we still love you – despite your poor corporate governance, declares Victor Hill.